drugset / Trial / NCT04944290
To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
RandomizedParallel-groupTriple-blindTreatment
Summary
To compare the efficacy and safety of Perrigo's product to an FDA approved product in the treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Both Eyes.
Timeline
- Start
- 2021-05-28
- Primary completion
- 2022-03-11
- Completion
- 2022-06-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brimonidine | Small molecule | 0.2 % | Other |
| Subject | Brinzolamide | Small molecule | 1 % | Other |